Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Preclinical Animal Model"”.
-
Development, validation, and characterization of a novel preclinical animal model of social familiarity-induced anxiolysis
… basic mechanisms is the development of a valid preclinical animal model. However, preclinical behavioral models exploring the use of a social presence in reducing anxiety have not been fully characterized. Therefore, it was our goal to identify a useful way in which to study the mechanisms of …
-
Investigating the effects of subthalamic nucleus stimulation on gait and pedunculopontine nucleus activity in a preclinical animal model of Parkinson’s disease
… severity in the MPTP non-human primate model of Parkinson’s disease, (2) characterizing changes in gait parameters with targeted subthalamic deep brain stimulation, and (3) defining how targeted subthalamic deep brain stimulation differentially affects neuronal spike rate and pattern …
-
PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioural and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.
… to be effective in treating the MK-801 induced preclinical animal model of schizophrenia without causing the adverse effects induced by currently prescribed antipsychotic drugs. The objective of this study was to evaluate PAOPA’s ability to treat behavioural abnormalities in an …
-
Cerebral ischemia in experimental subarachnoid hemorrhage
… treatment exists to prevent this condition. Animal models of this disease have so far only provided information on a particular aspect of DIND, e.g. the occurrence of delayed cerebral vasospasm. The present work focuses on the characterization of cerebral blood flow (CBF), cerebrospinal fluid …
-
Behaviors Disrupted due to Over-Expression of Tau in the Cholinergic Pedunculopontine Tegmentum
… efforts are hindered by the lack of an adequate preclinical animal model. We hypothesize the complete loss of cholinergic neurons within the PPTg, in addition to the deposition of tau in the PPTg via virally mediated overexpression, and the subsequent distribution of tau along PPTg projections, …
-
Personalized computational models of deep brain stimulation
… designs with more electrodes and computational models that can predict cellular modulation during DBS. Here, we developed a personalized computational modeling framework to (1) thoroughly investigate the electrode design parameter space for current and future DBS array designs, (2) generate and …
-
A PRO-RESOLVING LIPID MEDIATOR FOR THE ATTENUATION OF OSTEOARTHRITIS PATHOLOGY
… OA in vitro in macrophages and in a preliminary preclinical animal model after a non-invasive anterior cruciate ligament rupture (ACLr). Murine RAW 264.7 macrophages were treated with RvD1 for 24-hours then stimulated with lipopolysaccharides and co-treated with RvD1. After 4-hours, the cells …
-
The Identification of MTF2-specific Synthetic Lethal Interactions in Refractory Acute Myeloid Leukemia Using CRISPR
… using a patient derived xenograft (PDX) preclinical animal model of AML using immunocompromised NOD scid gamma (NSG) mice.
-
CATECHOLAMINE REGULATED PROTEIN 40 (CRP40): CLINICAL IMPLICATIONS IN PARKINSON’S DISEASE
… brain tissue samples from a hemi-lesioned preclinical animal model of PD. Most recently, work done at the University of Laval in collaboration McMaster University suggests that levels of CRP40 mRNA are in deficit in blood platelet samples from a primate model of PD.</p> <p>The studies …
-
Characterization of the cortical electrophysiological effects of motor thalamic DBS and assessment of a pharmacological model for essential tremor
… of electrophysiological experiments in a large preclinical animal model, we investigated first how neuronal spike rates and patterns in M1 change during thalamic DBS and second how such changes might explain the clinical observations that (1) higher frequency pulse trains for thalamic DBS are …
-
The Effect of Typical and Atypical Antipsychotics on the MK-801 Induced Deficit in Behavioural Inhibition
… such, MK-801 has the potential to be used as a preclinical animal model of cognitive deficits that arise in schizophrenia. The present thesis sought to explore if typical and/or atypical antipsychotics have the ability to reverse deficits in behavioral inhibition (lack of extinction) seen …
-
Systemic inflammation and disease progression in Multiple Sclerosis
… of haemolysis by systemic inflammation in a preclinical animal model.<br/>In summary, neurodegeneration in individuals with progressive MS may be impacted by both symptomatic and unknown, or asymptomatic, systemic inflammatory events. Further work is required to establish the importance of …
-
Advancing preclinical laser interstitial thermal therapy research through the establishment and validation of a murine model of glioblastoma
… resection. However, a well-characterized murine model for LITT treatment of GB is lacking, which hinders preclinical research. Methods: Syngeneic glioma cell line CT2A was orthotopically implanted into male C57BL/6 mice aged 8-12 weeks using a stereotactic frame. Tumor burden was assessed using …
-
Investigation of Sarcopenia in a Murine Model: Symptoms of Age-Related Neuromuscular Decline and Resistance Training Intervention
… largely undefined. Thus, there is a need for animal models for preclinical investigation of novel interventions. The overall purpose was to first investigate, characterize, and describe the neuromuscular healthspan of the C57BL/6 mouse, a common animal model of aging, and then to subsequently …
-
Novel Approach to Optimize the Laying Hen Model of Ovarian Cancer
… die from the disease. Lack of a more predictive animal model has been an obstacle to progress in ovarian cancer research. It is hypothesized that laying hens, though not fully characterized, could be an optimal animal model for the study of human ovarian cancer initiation, progression, therapy …
-
“Triggered”: a transdisciplinary approach to investigating the impact of traumatic stress disorders on treatment outcomes for opioid use disorder
… and treatment of OUD. Aim 1 was to leverage a preclinical animal model in neuroscience to investigate how a fear memory cue may trigger recurrence of drug-seeking. Aim 2 was to examine how primary care clinicians incorporate principles of Trauma-Informed Care into OUD treatment based on …
-
Microencapsulated human islets as a therapy for type 1 diabetes
… Despite promising studies in various animal models, encapsulated human islet transplantation has so far not made an impact in the clinical setting. Many non-immunological and immunological factors such as limited islet availability, reduced immunoprotection, effect of the encapsulation …
-
Nanotechnology for the understanding and prevention of preterm birth
… not at high risk for PTB. We next developed an animal model to improved our understanding of the mechanisms leading to PTB. Prior work has described induction of intrauterine inflammation in mice with a single injection of LPS. Here, we have improved the reproducibility and potency of LPS in the …
-
Duchenne muscular dystrophy gene therapy in the canine model
… mdx mouse has been the most widely used animal model for DMD research over the last 30 years. Dystrophin-deficient DMD dogs have also gained prominence as a highly relevant preclinical animal model due to their high phenotypic homology to human DMD patients. Preclinical treatment studies …
-
Role of CGRP in the amygdala in pain-related synaptic plasticity and behavior
… undergo significant neuroplastic changes in a model of arthritic pain. \r\nImportantly, high levels of calcitonin gene-related peptide (CGRP) are present in the CeA, most notably in the latero-capsular part (CeLC), which is now defined as the \"nociceptive amygdala\". The parabrachio-amygdaloid …
Page 1 of 2